EIR Amphastar Pharmaceuticals May 2002

Robert Coleman FDA, Tamala Magee FDA, Kham Phommachanh FDA, Kim Thomas Cruse FDA$595.00 - Available Now

FDA investigators audited the Amphastar Pharmaceuticals - Rancho Cucamonga, CA, United States facility and issued inspectional observation (via FDA 483) on 02 May 2002.

Product details

  • Category:
  • Inspection end: 02 May 2002
  • Location: Rancho Cucamonga, United States
  • FEI: 3002936358
Add To Cart